Evidence map›Paper›PMID 33814916›Full record

ArticleInternational journal of tryptophan research : IJTR2021

Lack of Skeletal Muscle Serotonin Impairs Physical Performance.

Marion Falabrègue, Anne-Claire Boschat, Romain Jouffroy, Marieke Derquennes, Haidar Djemai, Sylvia Sanquer, Robert Barouki, Xavier Coumoul, Jean-François Toussaint, Olivier Hermine and 2 more

Open access · goldAbstract read
In one paragraph

Article in International journal of tryptophan research : IJTR, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.4field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Marion FalabrègueInstitute for Research in bioMedicine and Epidemiology of Sport (EA 7329), Paris, France.
Anne-Claire BoschatUniversité de Paris, France.
Romain JouffroyInstitute for Research in bioMedicine and Epidemiology of Sport (EA 7329), Paris, France.
Marieke DerquennesInstitute for Research in bioMedicine and Epidemiology of Sport (EA 7329), Paris, France.
Haidar DjemaiInstitute for Research in bioMedicine and Epidemiology of Sport (EA 7329), Paris, France.
Sylvia SanquerService de Biochimie Métabolomique et Protéomique, Hôpital Necker-Enfants malades, AP-HP, Paris, France.ORCID https://orcid.org/0000-0002-0347-6501
Robert BaroukiUniversité de Paris, France.
Xavier CoumoulUniversité de Paris, France.
Jean-François ToussaintInstitute for Research in bioMedicine and Epidemiology of Sport (EA 7329), Paris, France.
Olivier HermineGR-Ex, Université de Paris, France.
Philippe NoirezInstitute for Research in bioMedicine and Epidemiology of Sport (EA 7329), Paris, France.
Francine CôtéGR-Ex, Université de Paris, France.ORCID https://orcid.org/0000-0002-6496-7566
Inserm · FRHôpital Necker-Enfants Malades · FRUniversité Paris Cité · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Low levels of the neurotransmitter serotonin have been associated with the onset of depression. While traditional treatments include antidepressants, physical exercise has emerged as an alternative for patients with depressive disorders. Yet there remains the fundamental question of how exercise is sensed by the brain. The existence of a muscle-brain endocrine loop has been proposed: according to this scenario, exercise modulates metabolization of tryptophan into kynurenine within skeletal muscle, which in turn affects the brain, enhancing resistance to depression. But the breakdown of tryptophan into kynurenine during exercise may also alter serotonin synthesis and help limit depression. In this study, we investigated whether peripheral serotonin might play a role in muscle-brain communication permitting adaptation for endurance training. We first quantified tryptophan metabolites in the blood of 4 trained athletes before and after a long-distance trail race and correlated changes in tryptophan metabolism with physical performance. In parallel, to assess exercise capacity and endurance in trained control and peripheral serotonin-deficient mice, we used a treadmill incremental test. Peripheral serotonin-deficient mice exhibited a significant drop in physical performance despite endurance training. Brain levels of tryptophan metabolites were similar in wild-type and peripheral serotonin-deficient animals, and no products of muscle-induced tryptophan metabolism were found in the plasma or brains of peripheral serotonin-deficient mice. But mass spectrometric analyses revealed a significant decrease in levels of 5-hydroxyindoleacetic acid (5-HIAA), the main serotonin metabolite, in both the soleus and plantaris muscles, demonstrating that metabolization of tryptophan into serotonin in muscles is essential for adaptation to endurance training. In light of these findings, the breakdown of tryptophan into peripheral but not brain serotonin appears to be the rate-limiting step for muscle adaptation to endurance training. The data suggest that there is a peripheral mechanism responsible for the positive effects of exercise, and that muscles are secretory organs with autocrine-paracrine roles in which serotonin has a local effect.

Indexed as

KynureninePeripheral and Central SerotoninPhysical performanceTryptophan

Identifiers

PMID33814916
PMCPMC7989111
OpenAlexW3139127871

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.